eBangor

A Risk–Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary Intervention

Guzauskas, G.F. and Hughes, D.A. and Bradley, S.M. and Veenstra, D.L. (2012) A Risk–Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary Intervention. Clinical Pharmacology & Therapeutics. DOI: 10.1038/clpt.2011.303

Full text not available from this repository.
Item Type: Article
Subjects: Research Publications
Departments: College of Health and Behavioural Sciences > Institute of Medical & Social Care Research
Date Deposited: 09 Dec 2014 16:54
Last Modified: 23 Sep 2015 03:14
ISSN: 0009-9236
URI: http://e.bangor.ac.uk/id/eprint/1407
Identification Number: DOI: 10.1038/clpt.2011.303
Publisher: Unknown
Administer Item Administer Item

eBangor is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.